Direct effects of exendin-(9,39) and GLP-1-(9,36)amide on insulin action, β-cell function, and glucose metabolism in nondiabetic subjects

  • Matheni Sathananthan
  • , Luca P. Farrugia
  • , John M. Miles
  • , Francesca Piccinini
  • , Chiara Dalla Man
  • , Alan R. Zinsmeister
  • , Claudio Cobelli
  • , Adrian Vella

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2752-2756
Number of pages5
JournalDiabetes
Volume62
Issue number8
DOIs
StatePublished - Aug 2013
Externally publishedYes

ASJC Scopus Subject Areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Keywords

  • Body Mass Index
  • Glucagon-Like Peptide 1/analogs & derivatives
  • Insulin-Secreting Cells/drug effects
  • Peptide Fragments/pharmacology
  • Blood Glucose/metabolism
  • Humans
  • Insulin/metabolism
  • Peptides/pharmacology
  • Adult
  • Female
  • Male
  • Glucagon/metabolism

Cite this